X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

July 10, 2019

Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

In 2015, the FDA shed light on a problematic practice within the healthcare industry involving improper, off-label use of syringes as closed container storage systems for compounded or repackaged drugs. The incidents cited revealed that interaction with rubber plungers in syringes that were not cleared for the purpose of closed container storage resulted in the loss of potency of several drugs when administration was delayed.<sup>1</sup>
Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    Elastomers

    June 25, 2019

    Bromobutyl versus Chlorobutyl Rubber Formulations - General Aspects

    Heike Kofler

    Dr. Heike Kofler

    Manager, Technical Customer Support Europe

    Ready Pack System

    March 12, 2019

    Molecule to Market – Simplify the Journey™ for New Drug Products

    Cathy Chhour

    Cathy Chhour

    Sr. Technical Account Specialist, TCS

    AccelTRA Program

    October 30, 2018

    As Average Time to Market Decreases, Generics Manufacturers Seek High-Quality Solutions

    Daria Miller

    Daria Miller

    Senior Technical Account Specialist, TCS

    Daikyo D Sigma Stopper

    October 25, 2018

    Daikyo D Sigma® Stoppers – Innovation Excellence

    Katie Espenshade

    Katie Espenshade

    Technical Specialist SME, PFS, CZ & Combination Products

    Daikyo D Sigma

    October 05, 2018

    A Culture of Innovation Sparks High-Quality Daikyo D Sigma® Elastomer Components

    Piotr Wagner

    Piotr Wagner Ph.D.

    Sr. Specialist, Marketing, Product Management

    Load more